SCHEMBL13579366

SCHEMBL13579366

C/C=C/CCC1CCC(C2CCC(c3ccc(-c4ccc(OCC)c(F)c4F)cc3)CC2)OC1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13579518 0.99 FPR2 (0.31) FPR2
SCHEMBL13579510 0.99 FPR2 (0.31) FPR2
SCHEMBL13579414 0.95 FPR2 (0.30) FPR2
SCHEMBL13579486 0.95 FPR2 (0.30) FPR2
SCHEMBL13579311 0.95 FPR2 (0.31) FPR2
SCHEMBL13579370 0.94 FPR2 (0.31) FPR2
SCHEMBL13579398 0.94 FPR2 (0.31) FPR2
SCHEMBL13579422 0.94 FPR2 (0.31) FPR2
SCHEMBL13579514 0.93 FPR2 (0.31) FPR2
SCHEMBL13579522 0.93 FPR2 (0.31) FPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8372306-B2 Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2013-02-12 US disclosed
US-8372306-B2 Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2013-02-12 US disclosed
US-20090324854-A1 LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2009-12-31 US disclosed
US-20090324854-A1 LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090324854-A1 LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CTNND1, YWHAZ, OCIAD2 FPR2 2669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.